Terms: = Uterine cancer AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439
122 results:
1. Evaluation of the anti-cancer efficacy of lipid nanoparticles containing siRNA against HPV16 E6/E7 combined with cisplatin in a xenograft model of cervical cancer.
Kang SW; Kang OJ; Lee JY; Kim H; Jung H; Kim H; Lee SW; Kim YM; Choi EK
PLoS One; 2024; 19(2):e0298815. PubMed ID: 38363779
[TBL] [Abstract] [Full Text] [Related]
2. Association of HLA class I and II genes with cervical cancer susceptibility in a Han Chinese population.
Yao Y; Yan Z; Li C; Zhang S; Liu S; Zhang X; Shi L; Liu W; Shi L; Yao Y
HLA; 2024 Jan; 103(1):e15340. PubMed ID: 38212262
[TBL] [Abstract] [Full Text] [Related]
3. Proteogenomics Reveal the Overexpression of HLA-I in cancer.
Wang Y; Fenyö D
J Proteome Res; 2023 Nov; 22(11):3625-3639. PubMed ID: 37857377
[TBL] [Abstract] [Full Text] [Related]
4. Ensuring equity in the era of HLA-restricted cancer therapeutics.
Smithy JW; Blouin A; Diamond LC; Postow M
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36442912
[TBL] [Abstract] [Full Text] [Related]
5. In-silico analysis reveals Quinic acid as a multitargeted inhibitor against Cervical cancer.
Ahmad S; Sayeed S; Bano N; Sheikh K; Raza K
J Biomol Struct Dyn; 2023 Nov; 41(19):9770-9786. PubMed ID: 36379678
[TBL] [Abstract] [Full Text] [Related]
6. Identification of human leukocyte antigen in precancerous and cancerous cervical lesions from Ecuadorian women.
Mora MJ; de Los Ángeles Bayas-Rea R; Mejía L; Cruz C; Guerra S; Calle P; Sandoval DM; Galarza JM; Zapata-Mena S
Infect Genet Evol; 2022 Nov; 105():105365. PubMed ID: 36108945
[TBL] [Abstract] [Full Text] [Related]
7. Substantial variability in ovarian conservation at hysterectomy for endometrial hyperplasia.
Matsuo K; Violette CJ; Mandelbaum RS; Harris CA; Tavakoli A; Klar M; Shoupe D; Roman LD
Am J Obstet Gynecol; 2022 Aug; 227(2):255.e1-255.e18. PubMed ID: 35487326
[TBL] [Abstract] [Full Text] [Related]
8. Anatomical distribution of sentinel lymph nodes in patients with endometrial cancer: a multicenter study.
Restaino S; Buda A; Puppo A; Capozzi VA; Sozzi G; Casarin J; Gallitelli V; Murgia F; Vizzielli G; Baroni A; Corrado G; Pasciuto T; Ferrari D; Novelli A; Berretta R; Legge F; Vizza E; Chiantera V; Ghezzi F; Landoni F; Scambia G; Fanfani F
Int J Gynecol Cancer; 2022 Apr; 32(4):517-524. PubMed ID: 35110375
[TBL] [Abstract] [Full Text] [Related]
9. Heat Shock Protein 105 as an Immunotherapeutic Target for Patients With Cervical cancer.
Nosaka K; Suzuki S; Yoshikawa T; Shimomura M; Kitami K; Yoshida K; Yoshihara M; Kikkawa F; Nakatsura T; Kajiyama H
Anticancer Res; 2021 Oct; 41(10):4741-4751. PubMed ID: 34593423
[TBL] [Abstract] [Full Text] [Related]
10. Anti-cancer immunotherapy using cancer-derived multiple epitope-peptides cocktail vaccination clinical studies in patients with refractory/persistent disease of uterine cervical cancer and ovarian cancer [phase 2].
Takeuchi S; Kagabu M; Shoji T; Nitta Y; Sugiyama T; Sato J; Nakamura Y
Oncoimmunology; 2020 Nov; 9(1):1838189. PubMed ID: 33235818
[TBL] [Abstract] [Full Text] [Related]
11. Is hysterectomy necessary for the treatment of preinvasive stratified mucin producing intraepithelial lesions of the cervix?
Kahn R; Zhou ZN; Goyal A; Gamble C; Nicholson N; Caputo TA; Holcomb K; Frey MK; Chapman-Davis E
Int J Gynecol Cancer; 2020 Sep; 30(9):1298-1302. PubMed ID: 32448806
[TBL] [Abstract] [Full Text] [Related]
12. TEX19 promotes ovarian carcinoma progression and is a potential target for epitope vaccine immunotherapy.
Xu Z; Tang H; Zhang T; Sun M; Han Q; Xu J; Wei M; Yu Z
Life Sci; 2020 Jan; 241():117171. PubMed ID: 31843525
[TBL] [Abstract] [Full Text] [Related]
13. Association of hla-a, -B, DRB, and DQB Alleles with Persistent HPV-16 Infection in Women from Tamil Nadu, India.
Bhaskaran M; Murali SV; Rajaram B; Krishnasamy S; Devasena CS; Pathak A; Ravi V; Swaminathan K; Ayyappa A; Vedhantham S; Seshachalam A; ArunKumar G
Viral Immunol; 2019 Dec; 32(10):430-441. PubMed ID: 31800372
[TBL] [Abstract] [Full Text] [Related]
14. T-cell receptor gene therapy targeting melanoma-associated antigen-A4 by silencing of endogenous TCR inhibits tumor growth in mice and human.
Sun Q; Zhang X; Wang L; Gao X; Xiong Y; Liu L; Wei F; Yang L; Ren X
Cell Death Dis; 2019 Jun; 10(7):475. PubMed ID: 31209257
[TBL] [Abstract] [Full Text] [Related]
15. Delayed IL-21 treatment preferentially expands peptide-specific CD8
Kim SH; Park SY; Lim MC; Lee ES; Lee EG; Han SE; Kim YH; Kwon BS; Choi BK
Immunotherapy; 2019 Apr; 11(6):497-513. PubMed ID: 30760061
[TBL] [Abstract] [Full Text] [Related]
16. Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal cancer.
Lo W; Parkhurst M; Robbins PF; Tran E; Lu YC; Jia L; Gartner JJ; Pasetto A; Deniger D; Malekzadeh P; Shelton TE; Prickett T; Ray S; Kivitz S; Paria BC; Kriley I; Schrump DS; Rosenberg SA
Cancer Immunol Res; 2019 Apr; 7(4):534-543. PubMed ID: 30709841
[TBL] [Abstract] [Full Text] [Related]
17. T-cell receptor V and J usage paired with specific HLA alleles associates with distinct cervical cancer survival rates.
Roca AM; Chobrutskiy BI; Callahan BM; Blanck G
Hum Immunol; 2019 Apr; 80(4):237-242. PubMed ID: 30684568
[TBL] [Abstract] [Full Text] [Related]
18. hla-a*30:01 and hla-a*33:03 are the protective alleles while hla-a*01:01 serves as the susceptible gene for cervical cancer patients in Xinjiang, China.
Alifu M; Hu YH; Dong T; Wang RZ
J Cancer Res Ther; 2018; 14(6):1266-1272. PubMed ID: 30488842
[TBL] [Abstract] [Full Text] [Related]
19. TRB-J1 usage, in combination with the hla-a*01:01 allele, represents an apparent survival advantage for uterine corpus endometrial carcinoma: Comparisons with microscopic assessments of lymphocyte infiltrates.
Clark KR; Tong WL; Callahan BM; Yavorski JM; Tu YN; Blanck G
Int J Immunogenet; 2019 Feb; 46(1):31-37. PubMed ID: 30474304
[TBL] [Abstract] [Full Text] [Related]
20. Identification of trophoblast-specific elements in the HLA-C core promoter.
Johnson JK; Wright PW; Li H; Anderson SK
HLA; 2018 Nov; 92(5):288-297. PubMed ID: 30270560
[TBL] [Abstract] [Full Text] [Related]
[Next]
